News items related to:
-
1 July 2020
US records a single-day record of 52,789 cases, as President Trump says, “ I think that, at some point, that’s...
-
30 June 2020
US FDA issues guidance on development of COVID-19 vaccines, including that a vaccine would need to prevent or lessen the...
-
29 June 2020
• The US government announces that it has purchased over 90% of the remdesivir that Gilead will produce during the...
-
28 June 2020
• Globally, more than 10 million people have COVID-19 and over 500,000 of them have died. Source • US surpasses...
-
27 June 2020
The European Commission (EC) and Global Citizen hold the Global Goal concert, as part of a fundraising campaign for the...
-
26 June 2020
• The ACT-A releases its investment case for $31.3 billion, for its three pillars: COVID-19 vaccines, therapeutics and diagnostics. To...
-
25 June 2020
• The NIH claims joint ownership of the IP for Moderna’s COVID-19 vaccine, based on years of research and a...
-
24 June 2020
• Gilead announces a goal of producing two million treatment courses of remdesivir by December 2020 (with 190,000 available by...
-
23 June 2020
Cipla, a Gilead licensee, announces its plans to market Cipremi, a generic version of remdesivir, for $66 per vial (a...
-
22 June 2020
• Gilead announces phase I trials of an inhalable formulation of remdesivir,and plans to test it in people with COVID-19...
-
20 June 2020
• Favipiravir, an oral antiviral, is approved for treatment of mild-to-moderate COVID-19 in India, marketed as FabiFlu. Source • Brazil...
-
17 June 2020
• WHO announces that it is stopping the hydroxychloroquine (HCQ) arm of the Solidarity Trial, based on data that it...